Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Apellis Pharmaceuticals Inc (NASDAQ: APLS) closed the day trading at $27.44 down -16.85% from the previous closing price of $33.00. In other words, the price has decreased by -$16.85 from its previous closing price. On the day, 3.94 million shares were traded. APLS stock price reached its highest trading level at $30.375 during the session, while it also had its lowest trading level at $27.35.
Ratios:
For a better understanding of APLS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.73 and its Current Ratio is at 4.36. In the meantime, Its Debt-to-Equity ratio is 1.98 whereas as Long-Term Debt/Eq ratio is at 1.96.
On November 21, 2024, Morgan Stanley started tracking the stock assigning a Equal-Weight rating and target price of $31.
On October 25, 2024, RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and target price of $25.RBC Capital Mkts initiated its Sector Perform rating on October 25, 2024, with a $25 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 06 ’25 when Baumal Caroline sold 2,816 shares for $33.81 per share. The transaction valued at 95,215 led to the insider holds 55,560 shares of the business.
Baumal Caroline bought 2,816 shares of APLS for $95,213 on Jan 06 ’25. On Dec 23 ’24, another insider, Eisele Jeffrey, who serves as the Chief Development Officer of the company, sold 63 shares for $33.09 each. As a result, the insider received 2,085 and left with 57,145 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APLS now has a Market Capitalization of 3413344000 and an Enterprise Value of 3480104448. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.77 while its Price-to-Book (P/B) ratio in mrq is 14.13. Its current Enterprise Value per Revenue stands at 4.866 whereas that against EBITDA is -15.711.
Stock Price History:
The Beta on a monthly basis for APLS is 0.96, which has changed by -0.5861237 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, APLS has reached a high of $73.80, while it has fallen to a 52-week low of $24.34. The 50-Day Moving Average of the stock is -12.67%, while the 200-Day Moving Average is calculated to be -27.02%.
Shares Statistics:
Over the past 3-months, APLS traded about 3.08M shares per day on average, while over the past 10 days, APLS traded about 2154990 shares per day. A total of 122.07M shares are outstanding, with a floating share count of 101.56M. Insiders hold about 18.32% of the company’s shares, while institutions hold 92.54% stake in the company. Shares short for APLS as of 1734048000 were 20011664 with a Short Ratio of 6.97, compared to 1731628800 on 23182889. Therefore, it implies a Short% of Shares Outstanding of 20011664 and a Short% of Float of 22.03.
